§ Funding Round
Series A funding round for Centessa Pharmaceuticals raising $250M in February 2021
Series A funding round for Centessa Pharmaceuticals raising $250M in February 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
General AtlanticLEAD | — | — |
Vida VenturesLEAD | Organization | — |
| Organization | — | |
BVF Partners | — | — |
| Organization | — | |
| Organization | — | |
Franklin Templeton | — | — |
Janus Henderson InvestorsLEAD | — | — |
| Organization | — | |
Logos Capital | — | — |
Samsara BioCapital | — | — |
T. Rowe Price Associates | — | — |
| Organization | — | |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$250M
Top Valuation
-
Centessa Pharmaceuticals raised $250M in a Series A round.
The round was announced on 02/01/21.
The round was led by General Atlantic, Vida Ventures, Janus Henderson Investors.
